The United States Pneumococcal Testing market is seeing demand for molecular detection and serotyping technologies. CDC laboratory resources include real-time and conventional PCR methods for identifying pneumococcal serotypes.
The pneumococcal testing market is projected to grow from US$ 2.26 billion in 2025 to US$ 5.76 billion by 2034, registering a CAGR of 10.97% during 2026–2034....
